# Cma Microdialysis AB

- Location (FDA's records): North Chelmsford, MA
- FDA decisions: 4 (2002–2011): 4 510(k) clearances
- Product codes: GWM (4)
- Predicates its devices cite: 6 (4 its own); citations of its devices by later devices: 4 (4 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Integra Neurosciences: 1 (https://510kreport.com/company/integra-neurosciences)
- Diametrics Medical, Inc.: 1 (https://510kreport.com/company/diametrics-medical)

## Its most-cited devices
- K020285: Cma Cerebral Tissue Monitoring System (2002), cited by 2
- K060554: Cma Cerebral Tissue Monitoring System (2006), cited by 1
- K071984: Modification to Cma Cerebral Tissue Monitoring System (2008), cited by 1

## Recent decisions
- K102077: Modification to Cma Cerebral Tissue Monitoring System (Jan 14, 2011)
- K071984: Modification to Cma Cerebral Tissue Monitoring System (Jun 27, 2008)
- K060554: Cma Cerebral Tissue Monitoring System (May 2, 2006)
- K020285: Cma Cerebral Tissue Monitoring System (Oct 23, 2002)

Source page: https://510kreport.com/company/cma-microdialysis